Market Cap 14.11M
Revenue (ttm) 0.00
Net Income (ttm) -13.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 28,000
Avg Vol 57,960
Day's Range N/A - N/A
Shares Out 2.87M
Stochastic %K 18%
Beta 1.81
Analysts Strong Sell
Price Target $27.67

Company Profile

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions. The company is developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-...

Industry: Biotechnology
Sector: Healthcare
Phone: 904 300 0701
Address:
822 A1A North, Suite 306, Ponte Vedra, United States
dark_orchid
dark_orchid May. 12 at 3:50 PM
0 · Reply
History101
History101 May. 12 at 1:33 AM
$CVKD not on my watchlist anymore, not until they can secure some funding.
0 · Reply
Hart4Charts
Hart4Charts May. 11 at 6:06 PM
0 · Reply
mikesterz7
mikesterz7 May. 10 at 3:45 PM
$CVKD The company plans a randomized, blinded, placebo-controlled pivotal Phase 3 (~120 patients) to support a projected NDA submission in 2029.
1 · Reply
Investor203
Investor203 May. 10 at 2:58 PM
0 · Reply
ZacksSCR
ZacksSCR May. 8 at 4:17 PM
$CVKD Designing Phase 3 Trial for CAD-1005 in HIT https://buff.ly/BXrJgse
0 · Reply
options1315
options1315 May. 8 at 2:19 AM
$CVKD scam. I knew it the first time all the scam bots started pumping this junk!!!!
0 · Reply
Monkey7779192
Monkey7779192 May. 8 at 12:17 AM
$CVKD Odd here. Being pumped by multiple account by a loser pr a scammer.
0 · Reply
focafoca99
focafoca99 May. 7 at 1:04 PM
$CVKD released its quarter ended March 31, 2026 financial results.
0 · Reply
Vaderesking
Vaderesking May. 6 at 12:55 PM
We Post Everyday, it's free, we do not sell anything, we do it to better our skillset. Keep us accountable. $SPY Test is complete, the run occurred and we are mid-week, every fiber of your body should be telling you to take profits and sit out the rest, and that would be the right thing to do. Conversely, watch 727.07, if we stay above continuation is on the table. $NQ Stuck in this zone, needs over 28514.25 or under 24822. $QQQ This 688.3 is key, we need to remain over it. Under I would expect a test of 683.08. $RTY 2872.2 test imminent here, I’m watching $CVKD, needs over $7.
0 · Reply
Latest News on CVKD
Cadrenal Therapeutics Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 22 days ago

Cadrenal Therapeutics Quarterly report: Q1 2026


Cadrenal Therapeutics Earnings release: Q1 2026

May 7, 2026, 7:00 AM EDT - 22 days ago

Cadrenal Therapeutics Earnings release: Q1 2026


Cadrenal Therapeutics Slides: Investor presentation

May 4, 2026, 7:00 AM EDT - 25 days ago

Cadrenal Therapeutics Slides: Investor presentation


Cadrenal Therapeutics Inc trading resumes

2026-04-01T19:35:16.000Z - 2 months ago

Cadrenal Therapeutics Inc trading resumes


Cadrenal Therapeutics Annual report: Q4 2025

Mar 31, 2026, 9:00 AM EDT - 2 months ago

Cadrenal Therapeutics Annual report: Q4 2025


Cadrenal Therapeutics Earnings release: Q4 2025

Mar 31, 2026, 9:00 AM EDT - 2 months ago

Cadrenal Therapeutics Earnings release: Q4 2025


Cadrenal Therapeutics highlights research on 12-LOX inhibition

2026-03-12T12:21:38.000Z - 2 months ago

Cadrenal Therapeutics highlights research on 12-LOX inhibition


Cadrenal Therapeutics announces Phase 2 results for CAD-1005

2026-02-24T13:39:32.000Z - 3 months ago

Cadrenal Therapeutics announces Phase 2 results for CAD-1005


Cadrenal's Quiet Expansion Play Is Starting to Get Loud

Dec 12, 2025, 11:00 AM EST - 6 months ago

Cadrenal's Quiet Expansion Play Is Starting to Get Loud


Cadrenal Therapeutics Slides: Investor presentation

Dec 11, 2025, 7:00 AM EST - 6 months ago

Cadrenal Therapeutics Slides: Investor presentation


Cadrenal Therapeutics Earnings release: Q3 2025

Nov 10, 2025, 9:00 AM EST - 7 months ago

Cadrenal Therapeutics Earnings release: Q3 2025


Cadrenal Therapeutics Quarterly report: Q3 2025

Nov 10, 2025, 9:00 AM EST - 7 months ago

Cadrenal Therapeutics Quarterly report: Q3 2025


Cadrenal Therapeutics reports Q2 EPS ($1.87), consensus ($1.77)

2025-08-11T12:20:21.000Z - 10 months ago

Cadrenal Therapeutics reports Q2 EPS ($1.87), consensus ($1.77)


Cadrenal Therapeutics Earnings release: Q2 2025

Aug 11, 2025, 7:00 AM EDT - 10 months ago

Cadrenal Therapeutics Earnings release: Q2 2025


Cadrenal Therapeutics Quarterly report: Q2 2025

Aug 11, 2025, 7:00 AM EDT - 10 months ago

Cadrenal Therapeutics Quarterly report: Q2 2025


Cadrenal Therapeutics announces trial plans for tecarfarin

2025-08-05T10:25:11.000Z - 10 months ago

Cadrenal Therapeutics announces trial plans for tecarfarin


Cadrenal Therapeutics Proxy statement: Proxy Filing

Jul 31, 2025, 8:00 AM EDT - 10 months ago

Cadrenal Therapeutics Proxy statement: Proxy Filing


Cadrenal Therapeutics Proxy statement: Proxy Filing

Jul 31, 2025, 8:00 AM EDT - 10 months ago

Cadrenal Therapeutics Proxy statement: Proxy Filing


Cadrenal Therapeutics Earnings release: Q1 2025

May 8, 2025, 4:00 PM EDT - 1 year ago

Cadrenal Therapeutics Earnings release: Q1 2025


Cadrenal Therapeutics Quarterly report: Q1 2025

May 8, 2025, 4:00 PM EDT - 1 year ago

Cadrenal Therapeutics Quarterly report: Q1 2025


Cadrenal Therapeutics Earnings release: Q4 2024

Mar 13, 2025, 9:30 AM EDT - 1 year ago

Cadrenal Therapeutics Earnings release: Q4 2024


Cadrenal Therapeutics Annual report: Q4 2024

Mar 13, 2025, 9:30 AM EDT - 1 year ago

Cadrenal Therapeutics Annual report: Q4 2024


Cadrenal Therapeutics  teams with Abbott inTECH-LVAD trial

2025-03-04T13:21:36.000Z - 1 year ago

Cadrenal Therapeutics teams with Abbott inTECH-LVAD trial

ABT


Cadrenal Therapeutics Quarterly report: Q3 2024

Nov 7, 2024, 4:00 PM EST - 1 year ago

Cadrenal Therapeutics Quarterly report: Q3 2024


Cadrenal Therapeutics Quarterly report: Q2 2024

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Cadrenal Therapeutics Quarterly report: Q2 2024


Cadrenal Therapeutics Earnings release: Q2 2024

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Cadrenal Therapeutics Earnings release: Q2 2024


Cadrenal Therapeutics Proxy statement: Proxy Filing

Jun 12, 2024, 8:00 AM EDT - 2 years ago

Cadrenal Therapeutics Proxy statement: Proxy Filing


Cadrenal Therapeutics Proxy statement: Proxy Filing

Jun 11, 2024, 8:00 AM EDT - 2 years ago

Cadrenal Therapeutics Proxy statement: Proxy Filing


dark_orchid
dark_orchid May. 12 at 3:50 PM
0 · Reply
History101
History101 May. 12 at 1:33 AM
$CVKD not on my watchlist anymore, not until they can secure some funding.
0 · Reply
Hart4Charts
Hart4Charts May. 11 at 6:06 PM
0 · Reply
mikesterz7
mikesterz7 May. 10 at 3:45 PM
$CVKD The company plans a randomized, blinded, placebo-controlled pivotal Phase 3 (~120 patients) to support a projected NDA submission in 2029.
1 · Reply
Investor203
Investor203 May. 10 at 2:58 PM
0 · Reply
ZacksSCR
ZacksSCR May. 8 at 4:17 PM
$CVKD Designing Phase 3 Trial for CAD-1005 in HIT https://buff.ly/BXrJgse
0 · Reply
options1315
options1315 May. 8 at 2:19 AM
$CVKD scam. I knew it the first time all the scam bots started pumping this junk!!!!
0 · Reply
Monkey7779192
Monkey7779192 May. 8 at 12:17 AM
$CVKD Odd here. Being pumped by multiple account by a loser pr a scammer.
0 · Reply
focafoca99
focafoca99 May. 7 at 1:04 PM
$CVKD released its quarter ended March 31, 2026 financial results.
0 · Reply
Vaderesking
Vaderesking May. 6 at 12:55 PM
We Post Everyday, it's free, we do not sell anything, we do it to better our skillset. Keep us accountable. $SPY Test is complete, the run occurred and we are mid-week, every fiber of your body should be telling you to take profits and sit out the rest, and that would be the right thing to do. Conversely, watch 727.07, if we stay above continuation is on the table. $NQ Stuck in this zone, needs over 28514.25 or under 24822. $QQQ This 688.3 is key, we need to remain over it. Under I would expect a test of 683.08. $RTY 2872.2 test imminent here, I’m watching $CVKD, needs over $7.
0 · Reply
M00nM00
M00nM00 May. 6 at 10:15 AM
$CVKD Bots spamming boards is a sign of it being a
0 · Reply
DonVigo
DonVigo May. 6 at 9:31 AM
$CVKD $SNDK $DGXX Blocked 🚫
0 · Reply
LittleBobbyAxelrod
LittleBobbyAxelrod May. 4 at 4:22 PM
$CVKD $SPY $GME $QQQ I thought i blocked you.
0 · Reply
DonVigo
DonVigo May. 4 at 3:31 PM
$CVKD $SOUN $CRCL Blocked 🚫
0 · Reply
mikesterz7
mikesterz7 May. 4 at 2:18 AM
$CVKD Its late-stage trial targets 120 patients globally, with results aimed at pushing for a potential NDA filing in 2029.
0 · Reply
DJTourettes
DJTourettes May. 4 at 1:55 AM
$CVKD $DJT $SNDK Yeah You should stop posting it Your five followers will get pissed 🤣🤣🤣🤣
1 · Reply
StocktwitsNews
StocktwitsNews May. 4 at 12:59 AM
CVKD Stock Retail Sentiment Peaks After FDA Clears Phase 3 Path For Blood Clot Drug $CVKD https://stocktwits.com/news/equity/markets/cvkd-stock-retail-sentiment-peaks-fda-phase-3-blood-clot-drug/cZQMBE6Re7h
0 · Reply